Hypertension Caused by Lenvatinib and Everolimus in the Treatment of Metastatic Renal Cell Carcinoma

Multikinase inhibitors (MKI) and mammalian target of rapamycin (mTOR) inhibitors prolong progression-free (PFS) and overall survival (OS) in the treatment of metastatic renal cell carcinoma (mRCC) by reducing angiogenesis and tumor growth. In this regard, the MKI lenvatinib and the mTOR inhibitor ev...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Mol Sci
Main Authors: Bendtsen, Mathias Alrø Fichtner, Grimm, Daniela, Bauer, Johann, Wehland, Markus, Wise, Petra, Magnusson, Nils E., Infanger, Manfred, Krüger, Marcus
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2017
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5578126/
https://ncbi.nlm.nih.gov/pubmed/28796163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18081736
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker